106 related articles for article (PubMed ID: 31371994)
1. MicroRNA-652 suppresses malignant phenotypes in glioblastoma multiforme via FOXK1-mediated AKT/mTOR signaling pathway.
Yang H; Song Z; Wu X; Wu Y; Liu C
Onco Targets Ther; 2019; 12():5563-5575. PubMed ID: 31371994
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92b targets tumor suppressor gene FBXW7 in glioblastoma.
Grafals-Ruiz N; Sánchez-Álvarez AO; Santana-Rivera Y; Lozada-Delgado EL; Rabelo-Fernandez RJ; Rios-Vicil CI; Valiyeva F; Vivas-Mejia PE
Front Oncol; 2023; 13():1249649. PubMed ID: 37752997
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA 3928 Suppresses Glioblastoma through Downregulation of Several Oncogenes and Upregulation of p53.
Mulcahy EQX; Zhang Y; Colόn RR; Cain SR; Gibert MK; Dube CJ; Hafner M; Abounader R
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409289
[TBL] [Abstract][Full Text] [Related]
4. CD300A inhibits tumor cell growth by downregulating AKT phosphorylation in human glioblastoma multiforme.
Du X; Liu B; Ding Q; He D; Zhang R; Yang F; Fan H; Teng L; Xin T
Int J Clin Exp Pathol; 2018; 11(7):3471-3478. PubMed ID: 31949725
[TBL] [Abstract][Full Text] [Related]
5. TFAP4 promotes the growth of prostate cancer cells by upregulating FOXK1.
Gu Y; Jiang J; Liang C
Exp Ther Med; 2021 Nov; 22(5):1299. PubMed ID: 34630654
[TBL] [Abstract][Full Text] [Related]
6. AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway.
Gao L; Liu J; Xu P; Deng G; Liu B; Yuan F; Tan Y; Sun Q; Xu Y; Zhang H; Qi Y; Han S; Yang K; Geng R; Jiang H; Chen Q
Front Pharmacol; 2020; 11():1102. PubMed ID: 32848734
[TBL] [Abstract][Full Text] [Related]
7. PDIA4 promotes glioblastoma progression via the PI3K/AKT/m-TOR pathway.
Wang M; Zhang W; Liu Y; Ma Z; Xiang W; Wen Y; Zhang D; Li Y; Li Y; Li T; Chen L; Zhou J
Biochem Biophys Res Commun; 2022 Mar; 597():83-90. PubMed ID: 35131603
[TBL] [Abstract][Full Text] [Related]
8. FOXK1 promotes hormonally responsive breast carcinogenesis by suppressing apoptosis.
Zhao M; Ma T; Zhang Z; Wang Y; Wang X; Wang W; Chen X; Gao R; Shan L
Animal Model Exp Med; 2024 Jan; ():. PubMed ID: 38238876
[TBL] [Abstract][Full Text] [Related]
9. Crebanine, an aporphine alkaloid, induces cancer cell apoptosis through PI3K-Akt pathway in glioblastoma multiforme.
Yeh PS; Liu CT; Yu CY; Chang YC; Lin SY; Li YC; Luan YZ; Sung WW
Front Pharmacol; 2024; 15():1419044. PubMed ID: 38895635
[TBL] [Abstract][Full Text] [Related]
10. RBM24 Suppresses the Tumorigenesis of Glioblastoma by Stabilizing LATS1 mRNA.
Lu X; Xie Y; Ding G; Sun W; Ye H
Biochem Genet; 2024 Mar; ():. PubMed ID: 38499965
[TBL] [Abstract][Full Text] [Related]
11. STAC1 is required for glioblastoma cell invasion and survival.
Yoon Y; Yoo CR; Kim EC; Han J; Yoon K
Biochem Biophys Res Commun; 2023 Sep; 674():75-82. PubMed ID: 37413708
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the impact of miR-21 on apoptosis regulation in glioblastoma.
Shaikh MAJ; Altamimi ASA; Afzal M; Gupta G; Singla N; Gilhotra R; Almalki WH; Kazmi I; Alzarea SI; Prasher P; Singh SK; Dua K
Pathol Res Pract; 2024 Feb; 254():155121. PubMed ID: 38262269
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAcylation of FOXK1 orchestrates the E2F pathway and promotes oncogenesis.
Masclef L; Ahmed O; Iannantuono N; Gagnon J; Gushul-Leclaire M; Boulay K; Estavoyer B; Echbicheb M; Poy M; Boubacar KA; Boubekeur A; Menggad S; Schcolnik-Cabrera A; Balsalobre A; Bonneil E; Thibault P; Hulea L; Tanaka Y; Antoine-Mallette F; Drouin J; Affar EB
bioRxiv; 2024 Mar; ():. PubMed ID: 38463952
[TBL] [Abstract][Full Text] [Related]
14. Fatty Acids Rich Extract From
Erukainure OL; Ashraf N; Naqvi AS; Zaruwa MZ; Muhammad A; Odusote AD; Elemo GN
Front Pharmacol; 2018; 9():251. PubMed ID: 29615913
[TBL] [Abstract][Full Text] [Related]
15. Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration.
Brosch PK; Korsa T; Taban D; Eiring P; Hildebrand S; Neubauer J; Zimmermann H; Sauer M; Shirakashi R; Djuzenova CS; Sisario D; Sukhorukov VL
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497276
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-652 inhibits the biological characteristics of esophageal squamous cell carcinoma by directly targeting fibroblast growth factor receptor 1.
Zhen C; Huang J; Lu J
Exp Ther Med; 2019 Dec; 18(6):4473-4480. PubMed ID: 31777550
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1.
Cheng K; Feng L; Yu S; Yu C; Chi N
Onco Targets Ther; 2019; 12():11737-11750. PubMed ID: 32099382
[TBL] [Abstract][Full Text] [Related]
18. microRNA-564 inhibits the aggressive phenotypes of papillary thyroid cancer by directly targeting astrocyte-elevated gene-1.
Song Z; Yang H; Wu X; Kong C; Xu C
Onco Targets Ther; 2019; 12():4869-4881. PubMed ID: 31388302
[No Abstract] [Full Text] [Related]
19. Multiwalled carbon nanotubes co-delivering sorafenib and epidermal growth factor receptor siRNA enhanced tumor-suppressing effect on liver cancer.
Wen Z; Feng Y; Hu Y; Lian L; Huang H; Guo L; Chen S; Yang Q; Zhang M; Wan L; Xu K; Degejirifu ; Yan X
Aging (Albany NY); 2021 Jan; 13(2):1872-1882. PubMed ID: 33440348
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
